Skip to main content
. Author manuscript; available in PMC: 2020 Aug 5.
Published in final edited form as: J Clin Virol. 2020 Apr 11;127:104344. doi: 10.1016/j.jcv.2020.104344

Figure 1:

Figure 1:

Viral load of three seroconverters before and after initiation of ART

Viral load (VL) in HIV-1 RNA log10 copies/ml of three plasma panels from seroconverters (LSS102, LSS103, LSS104) from individuals with early ART initiation. Panel 1 consisted of 12 samples and began treatment around day 107, panel 2 with 14 samples that began treatment around day 91 and panel 3 with 13 samples that began treatment around day 44. Arrows indicate estimated day of ART treatment initiation in patients. All samples remained G4-Reactive in both LAB-plasma and POC-blood tests.